Related Experiment Video
Updated: Aug 9, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants
S A Papiris1, M Veith2, A I Papaioannou1
12nd Pulmonary Medicine Department, Medical School, General University Hospital "Attikon", National and Kapodistrian University of Athens, Greece 1 Rimini Street, Haidari 12462, Greece.
This study identified a wide range of rare Alpha-1 Antitrypsin Deficiency (AATD) variants in Greece, highlighting the need for genetic sequencing in diagnosis. These findings expand our understanding of AATD
Area of Science:
- Genetics
- Pulmonology
- Biochemistry
Background:
- Alpha-1 Antitrypsin Deficiency (AATD) is a genetic disorder.
- Pathogenic mutations for AATD are expanding beyond common PI*Z and PI*S variants.
- Understanding rare variants is crucial for comprehensive diagnosis and management.
Purpose of the Study:
- To investigate the genotype and clinical profile of Greek patients with AATD.
- To identify and characterize rare AATD variants in the Greek population.
- To expand knowledge on the geographical distribution of rare AATD variants in Europe.
Main Methods:
- Symptomatic adult patients with early-emphysema and low AAT levels were enrolled.
- Genetic analysis was performed using Luminex genotyping and gene sequencing.
- Samples were analyzed at the AAT Laboratory in Marburg, Germany.
Main Results:
- 45 adults were included, with 38 having pathogenic variants.
- A multiplicity of rare AATD variants and combinations were identified in two-thirds of patients.
- Significant differences in AAT levels were observed between genotypes (p=0.002).
Conclusions:
- Genotyping in Greece revealed diverse rare AATD variants and combinations, including unique ones.
- Gene sequencing proved necessary for accurate genetic diagnosis of AATD.
- Detection of rare genotypes can inform personalized preventive and therapeutic strategies for AATD.
Related Concept Videos
Inborn Errors of Metabolism
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Lysosomal Hydrolases
Cystic Fibrosis: Management
Sinus disease and chronic...
ATP Synthase: Mechanism
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

